Development of new biodegradable plastic formulations for the biomedical sector. The PHASAL project develops different bioplastic formulations that introduce PHB-HV with different loads of hydroxyvalerate (-HV) from the revaluation of organic waste. The objective is that these formulations, applicable to the health field, present advanced biodegradability and biocompatibility properties to minimize the environmental impact they present due to their poor recyclability. In this sense, PHASAL develops a complex rigid packaging system, such as a suture kit, and a direct medical application with controlled drug release, such as a transdermal patch. The new advanced formulations developed during [...]













